AR213736A1 - Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno) - Google Patents

Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno)

Info

Publication number
AR213736A1
AR213736A1 AR264159A AR26415976A AR213736A1 AR 213736 A1 AR213736 A1 AR 213736A1 AR 264159 A AR264159 A AR 264159A AR 26415976 A AR26415976 A AR 26415976A AR 213736 A1 AR213736 A1 AR 213736A1
Authority
AR
Argentina
Prior art keywords
ethyl
methyltho
alkylaminonitroethylene
alcoxy
guanidine
Prior art date
Application number
AR264159A
Other languages
English (en)
Spanish (es)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of AR213736A1 publication Critical patent/AR213736A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR264159A 1975-07-31 1976-07-30 Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno) AR213736A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31970/75A GB1564502A (en) 1975-07-31 1975-07-31 Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives

Publications (1)

Publication Number Publication Date
AR213736A1 true AR213736A1 (es) 1979-03-15

Family

ID=10331105

Family Applications (1)

Application Number Title Priority Date Filing Date
AR264159A AR213736A1 (es) 1975-07-31 1976-07-30 Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno)

Country Status (31)

Country Link
US (4) US4083983A (ja)
JP (2) JPS5219671A (ja)
AR (1) AR213736A1 (ja)
AT (1) AT356132B (ja)
AU (1) AU502752B2 (ja)
BE (1) BE844504A (ja)
BG (1) BG27368A3 (ja)
CA (1) CA1068711A (ja)
CH (1) CH624938A5 (ja)
CS (1) CS189018B2 (ja)
DD (1) DD125204A5 (ja)
DE (1) DE2634433A1 (ja)
DK (1) DK316176A (ja)
ES (1) ES450310A1 (ja)
FI (1) FI762193A (ja)
FR (1) FR2319343A1 (ja)
GB (1) GB1564502A (ja)
GR (1) GR60810B (ja)
HU (1) HU173778B (ja)
IE (1) IE43508B1 (ja)
IL (1) IL50005A (ja)
LU (1) LU75507A1 (ja)
NL (1) NL7608496A (ja)
NO (1) NO762661L (ja)
PH (1) PH14555A (ja)
PL (1) PL103684B1 (ja)
PT (1) PT65348B (ja)
SE (1) SE7608477L (ja)
SU (1) SU692558A3 (ja)
ZA (1) ZA764082B (ja)
ZM (1) ZM9876A1 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4928863A (ja) * 1972-07-13 1974-03-14
JPS5078968U (ja) * 1973-11-20 1975-07-08
ZA774220B (en) * 1976-07-28 1978-06-28 Smith Kline French Lab Pharmacologically active compounds
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
US4250316A (en) * 1978-11-24 1981-02-10 Bristol-Myers Company Pyridyl guanidine anti-ulcer agents
NL8000869A (nl) * 1979-02-16 1980-08-19 Eisai Co Ltd Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan.
PT74865B (en) * 1981-05-27 1983-12-07 Smithkline Beckman Corp Process of preparing a 2-(pyridylbutylamino)-pyrimidone and of its pharmaceutically acceptable salts
SE8204879D0 (sv) * 1982-08-26 1982-08-26 Haessle Ab Novel chemical intermediates
DE3232462A1 (de) * 1982-09-01 1984-03-01 Bayer Ag, 5090 Leverkusen 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPH0828166B2 (ja) * 1985-01-16 1996-03-21 松下電器産業株式会社 サ−モスタツト
AU660132B2 (en) * 1992-12-21 1995-06-08 Bayer Aktiengesellschaft Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
US5380734A (en) * 1993-04-15 1995-01-10 American Home Products Corporation N-cyanoamidine derivatives as anti-influenza agents
EP3813900A4 (en) 2018-06-29 2022-05-04 410 Medical, Inc. SYSTEMS, DEVICE AND METHOD FOR FILTERING AIR FROM A FLUID LINE
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3808336A (en) 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3908014A (en) * 1970-06-25 1975-09-23 Smith Kline French Lab Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
US4002759A (en) * 1973-05-17 1977-01-11 Smith Kline & French Laboratories Limited Pyridylbutylamino ethylene compounds
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4025527A (en) * 1973-07-13 1977-05-24 Smith Kline & French Laboratories Limited Certain thiazoles and oxazoles
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives

Also Published As

Publication number Publication date
US4215126A (en) 1980-07-29
BE844504A (fr) 1977-01-24
CS189018B2 (en) 1979-03-30
JPS617423B2 (ja) 1986-03-06
US4264608A (en) 1981-04-28
SE7608477L (sv) 1977-02-01
FR2319343A1 (fr) 1977-02-25
DE2634433A1 (de) 1977-02-03
JPS5219671A (en) 1977-02-15
PH14555A (en) 1981-09-24
IL50005A0 (en) 1976-09-30
NL7608496A (nl) 1977-02-02
LU75507A1 (ja) 1977-03-03
AT356132B (de) 1980-04-10
CH624938A5 (ja) 1981-08-31
ZA764082B (en) 1977-06-29
DD125204A5 (ja) 1977-04-06
AU502752B2 (en) 1979-08-09
GB1564502A (en) 1980-04-10
IL50005A (en) 1981-06-29
FR2319343B1 (ja) 1978-11-17
ES450310A1 (es) 1977-12-01
JPS60243069A (ja) 1985-12-03
GR60810B (en) 1978-08-30
BG27368A3 (en) 1979-10-12
NO762661L (ja) 1977-02-01
ZM9876A1 (en) 1977-09-21
PL103684B1 (pl) 1979-07-31
PT65348A (en) 1976-08-01
PT65348B (en) 1978-01-06
DK316176A (da) 1977-02-01
US4426526A (en) 1984-01-17
ATA552576A (de) 1979-09-15
FI762193A (ja) 1977-02-01
US4083983A (en) 1978-04-11
AU1645376A (en) 1978-02-02
IE43508L (en) 1977-01-31
IE43508B1 (en) 1981-03-11
HU173778B (hu) 1979-08-28
CA1068711A (en) 1979-12-25
SU692558A3 (ru) 1979-10-15

Similar Documents

Publication Publication Date Title
MX6387E (es) Procedimiento para la preparacion de n-(heterocicloaminocarbonil)arilsulfonamidas
AR215930A1 (es) Procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
AR222290A1 (es) Procedimiento para obtener derivados de 5-het'-metil-2-het-metiltio-etilamino o 2-het-butilamino pirimidin-4-ona
AR213736A1 (es) Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno)
MX5375E (es) Procedimiento para la preparacion de n-(diaminofosfinil)-arilcarboxamidas
AR230059A1 (es) Procedimiento para obtener derivados de piperidil-1-il-alcoxi o hidroxialcoxi-carboestirilo o 3,4-dihidrocarboestirilo
MX4067E (es) Procedimiento para la preparacion de esteres de i-tiazolinil o i-tiazinilbencimidazol
AR221428A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil-y de pirrolidinilmetil-benzamidas
MX143488A (es) Procedimiento para la preparacion de resorcinas
AR224110A1 (es) Procedimiento para la preparacion de derivados de 5(6)-benzimidazoles
AR210349A1 (es) Procedimiento para la preparacion de 6-coloro-2(piperacinil)piracina
MX4972E (es) Procedimiento mejorado para la preparacion de 7 beta-oxiimmino-acilcefalosporinas
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
MX4649E (es) Procedimiento para la preparacion de n-cicloalquilmetil-2-fenilaminoimidazolinas-(2)-substituidas
MX143639A (es) Procedimiento para la preparacion de compuestos disazoicos tetrarreactivos
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
AR209835A1 (es) Procedimiento para la preparacion de elastasa pancreatica
MX5594E (es) Procedimiento mejorado para la preparacion de derivados de n-trifluoroacetil-n-fosfonometilglicinatos
MX5191E (es) Procedimiento para la preparacion de derivados de n'-fenil-n-metilurea
MX147640A (es) Procedimiento para la preparacion de compuestos de 4 6-5-beta-sulfatoetilsulfonil-2-amino-fenol
MX3739E (es) Procedimiento para la preparacion de acilamino-penicilinas-6-substituida
AR225134A1 (es) Procedimiento para la preparacion de acidos 3,7-disustituidos-3-cefem-4-carboxilicos
MX144201A (es) Procedimiento mejorado para la preparacion de ciclohexanodionas (1,3)